BridgeBio Pharma (BBIO) Revenue (QoQ) (2020 - 2026)
BridgeBio Pharma (BBIO) Revenue (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | BridgeBio Pharma | 16.15 Bn | 15.22 Bn | 184.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.16% |
| Dec 31, 2025 | 27.74% |
| Sep 30, 2025 | 9.17% |
| Jun 30, 2025 | -5.20% |
| Mar 31, 2025 | 1,882.88% |
| Dec 31, 2024 | 115.30% |
| Sep 30, 2024 | 26.01% |
| Jun 30, 2024 | -98.97% |
| Mar 31, 2024 | 11,998.57% |
| Dec 31, 2023 | -57.35% |
| Sep 30, 2023 | 149.30% |
| Jun 30, 2023 | -10.13% |
| Mar 31, 2023 | -2.35% |
| Dec 31, 2022 | 453.25% |
| Sep 30, 2022 | -99.54% |
| Jun 30, 2022 | 4,253.36% |
| Mar 31, 2022 | -83.06% |
| Dec 31, 2021 | 326.62% |
| Sep 30, 2021 | -95.66% |
| Jun 30, 2021 | 11,593.51% |